Answers are grounded in this paper and cite their sources.
Fontan-associated protein losing enteropathy is a challenge to treat and is a major contributor to morbidity and mortality in patients with palliated single ventricle. Numerous strategies for management have been proposed, with confusion as to how best to stratify and implement care among the many treatments available. Medical management can be helpful in some, while novel lymphatic interventions hold potential for remission with good results. We review our institutional approach to protein losing enteropathy after Fontan operation and provide a suggested algorithm and pathway for effective care.
No takes yet. Share an insight, caveat, or question.
Rychik et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: